Riskpilot← Back to searchSign inGet full accessNivmed AB
ABActiveOrg 5592741283Snickarevägen 6General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK -1
-100% vs 2024
EBITDA margin
902900.0%
-123% vs 2024
Equity ratio
37.2%
Financial strength
Net profit 2025
SEK -9K
-129% vs 2024
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -9K | -123% |
| Net profit | SEK -9K | -129% |
| Total assets | SEK 271K | -44% |
| Equity | SEK 101K | -67% |
| Employees | 0 | — |
Legal name
Nivmed AB
Org number
5592741283
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget kommer att ha som verksamhet uthyrning av konsulttjänster inom vård och omsorg samt där med förenliga verksamheter. Konsulttjänsterna kommer kräva medicinsk kompetens. Andra verksamhetsområden omfattar föreläsningar och utbildning inom medicinsk vetenskap samt därutöver förenliga verksamheter. Därutöver kommer bolaget att äga och förvalta aktier, värdepapper, fonder samt fast och lös egendom.
Address
Snickarevägen 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 188 | 152 | 51 | 55 | −0 |
| Staff expenses | — | −6 | −3 | −3 | −0 |
| EBITDA | 172 | 118 | 31 | 40 | −9 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 172 | 118 | 31 | 40 | −9 |
| Net financials | — | — | — | — | — |
| Profit before tax | 173 | 118 | 31 | 40 | −9 |
| Tax | −37 | −24 | −6 | −8 | — |
| Net profit | 136 | 93 | 25 | 31 | −9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 242 | 392 | 432 | 482 | 271 |
| Equity | 161 | 254 | 279 | 310 | 101 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 81 | 138 | 153 | 172 | 170 |
| Total debt | 81 | 138 | 153 | 172 | 170 |
EBITDA margin
-902900.0%
This company
15.8%
Market median
-5714657% vs market
20212025
Equity ratio
37.2%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
-8.9%
This company
18.4%
Market median
-148% vs market
20212025
Net profit margin
-902900.0%
This company
8.1%
Market median
-11147014% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.69×
This company
0.62×
Market median
-173% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nivmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ida Viktoria Nivestam | Deputy Board Member | 0 companies |
| Axel Fredrik Nivestam | Board of Directors | 0 companies |